Cascadian Therapeutics Inc (CASC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2011 | 06-2011 | 03-2011 | 12-2010 | 09-2010 | |
| Sales | 0 | 0 | 145 | 5 | 4 |
| Gross Profit | N/A | N/A | 145 | 5 | 4 |
| Operating Expenses | 6,443 | 5,826 | 6,017 | 4,997 | 4,345 |
| Operating Income | -6,443 | -5,826 | -5,872 | -4,992 | -4,341 |
| Interest Expense | 179 | 175 | 99 | 0 | 0 |
| Other Income | 16,559 | -27,972 | -1,145 | -1,162 | -211 |
| Pre-tax Income | 9,937 | -33,973 | -7,116 | -6,154 | -4,552 |
| Income Tax | N/A | N/A | N/A | N/A | -200 |
| Net Income Continuous | 9,937 | -33,973 | -7,116 | -6,154 | -4,352 |
| Net Income | $9,937 | $-33,973 | $-7,116 | $-6,154 | $-4,352 |
| EPS Basic Total Ops | 1.44 | -5.46 | -1.44 | -1.26 | -1.02 |
| EPS Basic Continuous Ops | 1.42 | -5.44 | -1.42 | -1.29 | -1.01 |
| EPS Diluted Total Ops | -0.90 | -5.46 | -1.44 | -2.10 | -1.02 |
| EPS Diluted Continuous Ops | 1.34 | -5.44 | -1.42 | -1.28 | -1.01 |
| EBITDA(a) | $-6,289 | $-5,655 | $-5,745 | $-4,880 | $-4,224 |